Reviewed,
UniProtKB/Swiss-Prot P07320 (CRGD_HUMAN)
Last modified
July 7, 2009.
Version 109.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Gamma-crystallin D Alternative name(s): Gamma-D-crystallin Gamma-crystallin 4 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 174 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Crystallins are the dominant structural components of the vertebrate eye lens. |
| Subunit structure | Monomer By similarity. |
| Domain | Has a two-domain beta-structure, folded into four very similar Greek key motifs. |
| Involvement in disease | Defects in CRYGD are a cause of various types of autosomal dominant cataract [MIM:604219]. Cataracts are common major abnormalities of the eye that frequently cause blindness in infants. Defects in CRYGD are the cause of autosomal dominant non-nuclear polymorphic congenital cataract (PCC) [MIM:601286]; also known as polymorphic congenital cataract. PCC is characterized by a nonprogressive phenotype and partial opacity that has a variable location on the periphery between the fetal nucleus of the lens and the equator. The opacities are irregular and look similar to a bunch of grapes and may be present simultaneously in different lens layers. Ref.18 Ref.19 Defects in CRYGD are the cause of congenital cerulean cataract 3 (CCA3) [MIM:608983]; also known as congenital cataract blue dot type 3. CCA3 is a form of autosomal dominant congenital cataract (ADCC). Cerulean cataracts have peripheral bluish and white opacifications in concentric layers with occasional central lesions arranged radially. Although the opacities may be observed during fetal development and childhood, usually visual acuity is only mildly reduced until adulthood, when lens extraction is generally necessary. Ref.17 Defects in CRYGD are the cause of progressive punctate cataract [MIM:123690]. It is an autosomal dominant trait characterized by early postnatal onset. Ref.12 Ref.14 Defects in CRYGD are the cause of crystalline aculeiform cataract (CACA) [MIM:115700]. CACA is a congenital crystalline cataract characterized by fiberglass-like or needle-like crystals through or close to the axial regions of the lens. Ref.11 |
| Sequence similarities | Belongs to the beta/gamma-crystallin family. Contains 4 beta/gamma crystallin 'Greek key' domains. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Sensory transduction Vision |
| Cellular component | Eye lens protein |
| Coding sequence diversity | Polymorphism |
| Disease | Cataract Disease mutation |
| Domain | Repeat |
| PTM | Oxidation |
| Technical term | 3D-structure Complete proteome Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | cellular response to reactive oxygen species Inferred from direct assay. Source: UniProtKB visual perception Ref.12 Ref.16 Ref.17Inferred from mutant phenotype. Source: UniProtKB |
| Cellular component | soluble fraction Inferred from direct assay. Source: UniProtKB |
| Molecular function | protein binding Inferred from physical interaction. Source: UniProtKB structural constituent of eye lens Ref.10Non-traceable author statement. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.5 | |||||||||||||||||||||||||||||||||||||||||
| Chain | 2 – 174 | 173 | Gamma-crystallin D | PRO_0000057588 | ||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||
| Domain | 2 – 40 | 39 | Beta/gamma crystallin 'Greek key' 1 | |||||||||||||||||||||||||||||||||||||||||
| Domain | 41 – 83 | 43 | Beta/gamma crystallin 'Greek key' 2 | |||||||||||||||||||||||||||||||||||||||||
| Domain | 88 – 128 | 41 | Beta/gamma crystallin 'Greek key' 3 | |||||||||||||||||||||||||||||||||||||||||
| Domain | 129 – 171 | 43 | Beta/gamma crystallin 'Greek key' 4 | |||||||||||||||||||||||||||||||||||||||||
| Region | 84 – 87 | 4 | Connecting peptide | |||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||
| Site | 46 | 1 | Susceptible to oxidation | |||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 15 | 1 | R → C in progressive punctate cataract; forms disulfide-linked oligomers. Ref.12 Ref.14 | VAR_010733 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 24 | 1 | P → S in PCC. dbSNP rs28931605. Ref.19 | VAR_034955 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 24 | 1 | P → T in CCA3 and lamellar cataract; lowered solubility. | VAR_021145 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 37 | 1 | R → S in cataract; very low solubility; crystallizes spontaneously. Ref.13 Ref.15 | VAR_010734 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 59 | 1 | R → H in CACA; lowered solubility; crystallizes easily. Ref.11 | VAR_010735 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 102 | 1 | M → V Ref.1 Ref.16 | VAR_021146 | ||||||||||||||||||||||||||||||||||||||||
| Natural variant | 107 | 1 | E → A in PCC. Ref.18 | VAR_034956 | ||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 24 – 25 | 2 | PN → TK: Wild-type solubility. Ref.7 | |||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 24 | 1 | P → S: Lowered solubility, but more soluble than T-23. Ref.7 | |||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 24 | 1 | P → TP: Wild-type solubility. Ref.7 | |||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 24 | 1 | P → V: Slightly lowered solubility. Ref.7 | |||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 3 – 9 | 7 | ||||||||||||||||||||||||||||||||||||||||||
| Helix | 10 – 12 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 13 – 21 | 9 | ||||||||||||||||||||||||||||||||||||||||||
| Turn | 27 – 29 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 34 – 48 | 15 | ||||||||||||||||||||||||||||||||||||||||||
| Turn | 49 – 51 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 52 – 58 | 7 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 60 – 65 | 6 | ||||||||||||||||||||||||||||||||||||||||||
| Helix | 66 – 69 | 4 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 72 – 74 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 78 – 82 | 5 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 89 – 95 | 7 | ||||||||||||||||||||||||||||||||||||||||||
| Helix | 96 – 98 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 99 – 107 | 9 | ||||||||||||||||||||||||||||||||||||||||||
| Helix | 112 – 114 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 123 – 129 | 7 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 131 – 136 | 6 | ||||||||||||||||||||||||||||||||||||||||||
| Turn | 137 – 139 | 3 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 140 – 146 | 7 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 148 – 151 | 4 | ||||||||||||||||||||||||||||||||||||||||||
| Helix | 154 – 157 | 4 | ||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 166 – 169 | 4 | ||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Structural and evolutionary relationships among five members of the human gamma-crystallin gene family." Meakin S.O., Breitman M.L., Tsui L.-C. Mol. Cell. Biol. 5:1408-1414(1985) [PubMed: 4033658] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT VAL-102. |
| [2] | "Cloning and expression of human lens crystallins." Petrash J.M., Mathur S., Manoharan M., Andley U.P. Invest. Ophthalmol. Vis. Sci. 36:S882-S882(1995) Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Lens. |
| [3] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed: 15815621] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Testis. |
| [5] | "Sequence analysis of betaA3, betaB3, and betaA4 crystallins completes the identification of the major proteins in young human lens." Lampi K.J., Ma Z., Shih M., Shearer T.R., Smith J.B., Smith D.L., David L.L. J. Biol. Chem. 272:2268-2275(1997) [PubMed: 8999933] [Abstract] Cited for: PROTEIN SEQUENCE OF 2-11. |
| [6] | "Shotgun identification of protein modifications from protein complexes and lens tissue." MacCoss M.J., McDonald W.H., Saraf A., Sadygov R., Clark J.M., Tasto J.J., Gould K.L., Wolters D., Washburn M., Weiss A., Clark J.I., Yates J.R. III Proc. Natl. Acad. Sci. U.S.A. 99:7900-7905(2002) [PubMed: 12060738] [Abstract] Cited for: SUSCEPTIBILITY TO OXIDATION, MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [7] | "Decrease in protein solubility and cataract formation caused by the Pro23 to Thr mutation in human gamma D-crystallin." Pande A., Annunziata O., Asherie N., Ogun O., Benedek G.B., Pande J. Biochemistry 44:2491-2500(2005) [PubMed: 15709761] [Abstract] Cited for: MUTAGENESIS OF PRO-24. |
| [8] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [9] | "High-resolution X-ray crystal structures of human gammaD crystallin (1.25 A) and the R58H mutant (1.15 A) associated with aculeiform cataract." Basak A., Bateman O., Slingsby C., Pande A., Asherie N., Ogun O., Benedek G.B., Pande J. J. Mol. Biol. 328:1137-1147(2003) [PubMed: 12729747] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS), X-RAY CRYSTALLOGRAPHY (1.15 ANGSTROMS) OF VARIANT HIS-59. |
| [10] | "Homology models of human gamma-crystallins: structural study of the extensive charge network in gamma-crystallins." Salim A., Zaidi Z.H. Biochem. Biophys. Res. Commun. 300:624-630(2003) [PubMed: 12507494] [Abstract] Cited for: 3D-STRUCTURE MODELING. |
| [11] | "The gamma-crystallins and human cataracts: a puzzle made clearer." Heon E., Priston M., Schorderet D.F., Billingsley G.D., Girard P.O., Lubsen N., Munier F.L. Am. J. Hum. Genet. 65:1261-1267(1999) [PubMed: 10521291] [Abstract] Cited for: VARIANT CACA HIS-59. |
| [12] | "Progressive juvenile-onset punctate cataracts caused by mutation of the gamma-D-crystallin gene." Stephan D.A., Gillanders E., Vanderveen D., Freas-Lutz D., Wistow G., Baxevanis A.D., Robbins C.M., VanAuken A., Quesenberry M.I., Bailey-Wilson J., Juo S.-H.H., Trent J.M., Smith L., Brownstein M.J. Proc. Natl. Acad. Sci. U.S.A. 96:1008-1012(1999) [PubMed: 9927684] [Abstract] Cited for: VARIANT PROGRESSIVE PUNCTATE CATARACT CYS-15. |
| [13] | "Link between a novel human gamma-D-crystallin allele and a unique cataract phenotype explained by protein crystallography." Kmoch S., Brynda J., Asfaw B., Bezouska K., Novak P., Rezacova P., Ondrova L., Filipec M., Sedlacek J., Elleder M. Hum. Mol. Genet. 9:1779-1786(2000) [PubMed: 10915766] [Abstract] Cited for: VARIANT CATARACT SER-37. |
| [14] | "Molecular basis of a progressive juvenile-onset hereditary cataract." Pande A., Pande J., Asherie N., Lomakin A., Ogun O., King J.A., Lubsen N.H., Walton D., Benedek G.B. Proc. Natl. Acad. Sci. U.S.A. 97:1993-1998(2000) [PubMed: 10688888] [Abstract] Cited for: CHARACTERIZATION OF VARIANT PROGRESSIVE PUNCTATE CATARACT CYS-15. |
| [15] | "Crystal cataracts: human genetic cataract caused by protein crystallization." Pande A., Pande J., Asherie N., Lomakin A., Ogun O., King J., Benedek G.B. Proc. Natl. Acad. Sci. U.S.A. 98:6116-6120(2001) [PubMed: 11371638] [Abstract] Cited for: CHARACTERIZATION OF VARIANTS CATARACT SER-37 AND HIS-59. |
| [16] | "Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts." Santhiya S.T., Shyam Manohar M., Rawlley D., Vijayalakshmi P., Namperumalsamy P., Gopinath P.M., Loester J., Graw J. J. Med. Genet. 39:352-358(2002) [PubMed: 12011157] [Abstract] Cited for: VARIANT LAMELLAR CATARACT THR-24, VARIANT VAL-102. |
| [17] | "Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts." Nandrot E., Slingsby C., Basak A., Cherif-Chefchaouni M., Benazzouz B., Hajaji Y., Boutayeb S., Gribouval O., Arbogast L., Berraho A., Abitbol M., Hilal L. J. Med. Genet. 40:262-267(2003) [PubMed: 12676897] [Abstract] Cited for: VARIANT CCA3 THR-24. |
| [18] | "Two affected siblings with nuclear cataract associated with a novel missense mutation in the CRYGD gene." Messina-Baas O.M., Gonzalez-Huerta L.M., Cuevas-Covarrubias S.A. Mol. Vis. 12:995-1000(2006) [PubMed: 16943771] [Abstract] Cited for: VARIANT PCC ALA-107. |
| [19] | "Conversion and compensatory evolution of the gamma-crystallin genes and identification of a cataractogenic mutation that reverses the sequence of the human CRYGD gene to an ancestral state." Plotnikova O.V., Kondrashov F.A., Vlasov P.K., Grigorenko A.P., Ginter E.K., Rogaev E.I. Am. J. Hum. Genet. 81:32-43(2007) [PubMed: 17564961] [Abstract] Cited for: VARIANT PCC SER-24. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| K03006, K03005 Genomic DNA. Translation: AAA52112.1. U66583 mRNA. Translation: AAB38686.1. AC093698 Genomic DNA. Translation: AAY24041.1. BC117338 mRNA. Translation: AAI17339.1. BC117340 mRNA. Translation: AAI17341.1. | |||||||||||||||||||||||||||||||
| IPI | IPI00215881. | ||||||||||||||||||||||||||||||
| PIR | I77413. | ||||||||||||||||||||||||||||||
| RefSeq | NP_008822.2. | ||||||||||||||||||||||||||||||
| UniGene | Hs.546247 | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P07320. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PeptideAtlas | P07320. | ||||||||||||||||||||||||||||||
| PRIDE | P07320. | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENSG00000118231. Homo sapiens. [Contig view] | ||||||||||||||||||||||||||||||
| GeneID | 1421. | ||||||||||||||||||||||||||||||
| KEGG | hsa:1421. | ||||||||||||||||||||||||||||||
| UCSC | uc002vcn.2. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| GeneCards | GC02M208694. | ||||||||||||||||||||||||||||||
| H-InvDB | HIX0030025. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:2411. CRYGD. | ||||||||||||||||||||||||||||||
| MIM | 115700. phenotype. 123690. gene+phenotype. 601286. phenotype. 604219. phenotype. 608983. phenotype. | ||||||||||||||||||||||||||||||
| Orphanet | 98989. Cataract, cerulean. 98986. Cataract, Coppock-like. 91492. Non-syndromic congenital cataract. | ||||||||||||||||||||||||||||||
| PharmGKB | PA26918. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| HOGENOM | P07320. | ||||||||||||||||||||||||||||||
| HOVERGEN | P07320. | ||||||||||||||||||||||||||||||
| OMA | P07320. IPHAGSH. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P07320. | ||||||||||||||||||||||||||||||
| Bgee | P07320. | ||||||||||||||||||||||||||||||
| CleanEx | HS_CRYGD. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000118231. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR001064. Crystallin. [Graphical view] | ||||||||||||||||||||||||||||||
| Gene3D | G3DSA:2.60.20.10. Crystallin. 2 hits. | ||||||||||||||||||||||||||||||
| Pfam | PF00030. Crystall. 2 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| PRINTS | PR01367. BGCRYSTALLIN. | ||||||||||||||||||||||||||||||
| SMART | SM00247. XTALbg. 2 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS50915. CRYSTALLIN_BETA_GAMMA. 4 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||
| NextBio | 5811. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | CRGD_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P07320 Secondary accession number(s): Q17RF7, Q53R51, Q99681 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


